Fracture risk is a class effect of glitazones.
作者信息
Short Robert
出版信息
BMJ. 2007 Mar 17;334(7593):551. doi: 10.1136/bmj.39154.373889.DB.
Abstract
摘要
相似文献
1
Fracture risk is a class effect of glitazones.
BMJ. 2007 Mar 17;334(7593):551. doi: 10.1136/bmj.39154.373889.DB.
2
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
Diabetes Obes Metab. 2010 Aug;12(8):716-21. doi: 10.1111/j.1463-1326.2010.01225.x.
3
Diabetes drug pioglitazone (Actos): risk of fracture.
CMAJ. 2007 Sep 25;177(7):723-4. doi: 10.1503/cmaj.071177. Epub 2007 Sep 6.
4
[Thiazolidinediones and skeletal health].
Rev Med Suisse. 2009 Jun 10;5(207):1309-10, 1312-3.
5
Study confirms link between certain diabetes drugs and fractures.
Harv Womens Health Watch. 2010 May;17(9):6.
6
Considering competing risks . . . Not all black and white.
Arch Intern Med. 2008 Apr 28;168(8):793-5. doi: 10.1001/archinte.168.8.793.
7
Glitazones: fractures: avoid using glitazones.
Prescrire Int. 2008 Feb;17(93):23.
8
Use of thiazolidinediones and fracture risk.
Arch Intern Med. 2008 Apr 28;168(8):820-5. doi: 10.1001/archinte.168.8.820.
9
[Glitazones in type 2 diabetes--documented risks, uncertain benefits].
Lakartidningen. 2007;104(43):3198-200.
10
[Glitazones more than hypoglycemics in type 2 diabetes].
Lakartidningen. 2007;104(43):3201-3.
引用本文的文献
1
The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study.
Diabetologia. 2010 Mar;53(3):489-96. doi: 10.1007/s00125-009-1609-z. Epub 2009 Nov 27.
2
Risk of fractures with glitazones: a critical review of the evidence to date.
Drug Saf. 2009;32(7):539-47. doi: 10.2165/00002018-200932070-00001.
3
Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive.
Drug Saf. 2009;32(3):187-202. doi: 10.2165/00002018-200932030-00002.
4
Drug-induced osteoporosis: beyond glucocorticoids.
Curr Rheumatol Rep. 2008 Apr;10(2):102-9. doi: 10.1007/s11926-008-0019-4.
5
Diabetes, fracture, and bone fragility.
Curr Osteoporos Rep. 2007 Sep;5(3):105-11. doi: 10.1007/s11914-007-0025-x.
Zotero 插件